[
  {
    "donor_id": "D001",
    "specimen_id": "SOG002",
    "specimen_type": "Organoid",
    "entries": [
      {
        "type": "Panobinostat",
        "details": "Panobinostat exposure on organoids: 20 nM, 72h cycles with media refresh; selected as top GOF from DSA.",
        "start_date": "2024-07-02",
        "start_day": null,
        "end_date": "2024-07-16",
        "duration_days": null,
        "results": "~80–90% viability reduction by day 7; compact spheroid morphology and reduced proliferation markers."
      }
    ]
  },
  {
    "donor_id": "D003",
    "specimen_id": "SOG002",
    "specimen_type": "Organoid",
    "entries": [
      {
        "type": "Temozolomide",
        "details": "Temozolomide exposure on organoids: 100 μM, 48h on/24h off cycles; top GOF from DSA.",
        "start_date": "2022-09-20",
        "start_day": null,
        "end_date": "2022-10-04",
        "duration_days": null,
        "results": "~60–75% viability reduction; increased apoptosis markers; growth delay versus untreated." 
      }
    ]
  },
  {
    "donor_id": "D001",
    "specimen_id": "SXG002",
    "specimen_type": "Xenograft",
    "entries": [
      {
        "type": "Paclitaxel",
        "details": "Paclitaxel 10 mg/kg IV weekly ×3 starting at implantation; second-highest efficacy by GOF.",
        "start_date": "2024-07-09",
        "start_day": null,
        "end_date": "2024-07-30",
        "duration_days": null,
        "results": "Invasive growth retained; survival extended to 35–50 days (vs 30–45 untreated)."
      }
    ]
  },
  {
    "donor_id": "D001",
    "specimen_id": "SXG003",
    "specimen_type": "Xenograft",
    "entries": [
      {
        "type": "Panobinostat",
        "details": "Panobinostat 10 mg/kg IP qod ×14 days with matrix encapsulation; top drug by GOF.",
        "start_date": "2024-07-09",
        "start_day": null,
        "end_date": "2024-08-06",
        "duration_days": null,
        "results": "Encapsulated tumor growth with limited infiltration; survival 60–90 days."
      }
    ]
  },
  {
    "donor_id": "D003",
    "specimen_id": "SXG002",
    "specimen_type": "Xenograft",
    "entries": [
      {
        "type": "Selumetinib",
        "details": "Selumetinib 25 mg/kg PO bid ×21 days; second-best efficacy by GOF (tie-broken by GOF+DSSS).",
        "start_date": "2022-09-27",
        "start_day": null,
        "end_date": "2022-10-18",
        "duration_days": null,
        "results": "Invasive growth maintained; survival improved to 55–75 days (vs 50–70 untreated)."
      }
    ]
  },
  {
    "donor_id": "D003",
    "specimen_id": "SXG003",
    "specimen_type": "Xenograft",
    "entries": [
      {
        "type": "Temozolomide",
        "details": "Temozolomide 50 mg/kg PO daily 5/7 ×2 cycles; top drug by GOF.",
        "start_date": "2022-09-27",
        "start_day": null,
        "end_date": "2022-10-25",
        "duration_days": null,
        "results": "Encapsulated tumors with minimal invasion; survival 100–140 days."
      }
    ]
  }
]